Observation of Azithromycin followed by Clindamycin in The treatment of Pediatric Mycoplasma Pneumonia
Gao Xiao
Abstract
Gao Xiao
Abstract
Objective:To investigate the effect of Azithromycin followed by Clindamycin in the treatment of pediatricmycoplasma pneumonia.Methods: Patients with mycoplasma pneumonia were randomized divided into group A( Azithromycinthreated group, n=15) , group B( Clindamycin threated group, n=15) and group C( Azithromycin followed by Clindamycin threatedgroup, n=15) .In group A Azithromycin were given intravenously with the dosage of 10mg1kg1d for 3 days.In group B Clindamycinwere given intravenously with the dosage of 40mg1kg1d for 7 days.In group C Azithromycin were given intravenously with thedosage of 10mg1kg1d for 3 days, followed by Clindamycin giving intravenously with the dosage of 40mg1kg1d for 4 days.Results:The responsive rate of group C was significantly higher than that of group A or group B.The adverse reaction incidence ofClindamycin was lower than that of Azithromycin.Conclusion: The protocol of Azithromycin followed by Clindamycin gets betterresponsive to mycoplasma pneumonia in children compared to that of Azithromycin or Clindamycin.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effect of Azithromycin followed by Clindamycin in the treatment of pediatricmycoplasma pneumonia.Methods: Patients with mycoplasma pneumonia were randomized divided into group A( Azithromycinthreated group, n=15) , group B( Clindamycin threated group, n=15) and group C( Azithromycin followed by Clindamycin threatedgroup, n=15) .In group A Azithromycin were given intravenously with the dosage of 10mg1kg1d for 3 days.In group B Clindamycinwere given intravenously with the dosage of 40mg1kg1d for 7 days.In group C Azithromycin were given intravenously with thedosage of 10mg1kg1d for 3 days, followed by Clindamycin giving intravenously with the dosage of 40mg1kg1d for 4 days.Results:The responsive rate of group C was significantly higher than that of group A or group B.The adverse reaction incidence ofClindamycin was lower than that of Azithromycin.Conclusion: The protocol of Azithromycin followed by Clindamycin gets betterresponsive to mycoplasma pneumonia in children compared to that of Azithromycin or Clindamycin.
Key concepts: Azithromycin, Clindamycin, Medicine, Mycoplasma pneumonia, Pneumonia, Mycoplasma, Group B, Incidence (geometry)